Clinical diagnostic
solutions
solutions
Tumor diagnostic solutions
Combined with NeoHiT® PCR technology, Pregene Biotechnology has developed molecular diagnostic products that can simultaneously detect multiple specific biomarkers for tumors in different tissues and at different stages of development, which can provide
MARC肿瘤风险评估体系
高通量PCR肿瘤早筛/辅助诊断方案以MARC肿瘤风险评估体系为核心，融合了高通量PCR仪器系统、高通量检测试剂系统和智能化分析算法，为肿瘤的早期筛查、早期诊断和早期治疗提供了突破性的技术支持。普济生物独创MARC(Multi-marker Assessment of Risky Cancer) 肿瘤风险评估体系，建立多癌种多基因风险评估模型，输出MARC Score，高特异性区分高中低险人群，大幅提高肿瘤早筛准确性，助力多癌种精准诊疗。
Core Advantages
NeoHiT® PCR technology
Combined with NeoHiT® PCR technology, a single reaction system can cover dozens to hundreds of targets for a specific tumor.
Convenient detection operation
The detection operation is simple and the detection speed is fast, taking only 4 hours at least. It is more suitable for widespread use in clinical terminals.
Detection is more sensitive
The detection is more sensitive and can be absolutely quantitative, truly meeting the needs of liquid biopsy and dynamic monitoring.
Multi-sample compatible
Compatible with a variety of sample types, it has a wider range of clinical applications.
肿瘤早筛/辅助诊断产品列表
肺癌基因甲基化检测试剂盒
结直肠癌基因甲基化检测试剂盒
呼吸系统肿瘤早筛检测试剂盒
消化系统肿瘤早筛检测试剂盒
肿瘤伴随诊断产品列表
结直肠癌基因突变检测试剂盒
肺癌基因突变检测试剂盒
肺癌基因突变融合检测试剂盒
